©2022 Australasian Society of Clinical Immunology and Allergy (ASCIA)
ABN 45 615 521 452



Information updates

Bayer Novalac Allergy Infant Formula Update

Due to supply challenges, Bayer is expecting temporary out of stock of Novalac Allergy Infant Formula in pharmacies across Australia, with normal supply resuming late March to early April. Limited availability may continue in April in some pharmacies across Australia as stock levels rebuild. Other products in the Novalac range are not suitable for infants with cow’s milk protein allergy.

As the distributor of Novalac Allergy, Bayer is working closely with the global manufacturer to improve supply and apologise for this disruption, particularly as babies who are fed Novalac Allergy Infant Formula are vulnerable patients with specialised nutrition requirements.

Parents and carers are encouraged to contact their local pharmacy to check stock levels before going in-store. If they are unable to find Novalac Allergy in pharmacies, it is recommended that they speak to their healthcare professional who can provide medical advice about alternative products specifically for their baby, which are listed on the ASCIA website

Contact Bayer’s Medical Information Team on1800 008 757 or This email address is being protected from spambots. You need JavaScript enabled to view it. should you have any questions.


This news item was issued on 24 March 2022 by the Australasian Society of Clinical Immunology and Allergy (ASCIA), the peak professional body for clinical immunology and allergy in Australia and New Zealand.